Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Simcere Pharmaceutical Group Limited ( (HK:2096) ).
Simcere Pharmaceutical Group Limited announced an expected revenue increase for FY2024, with profits projected to rise significantly, largely due to growth in their innovative pharmaceutical business. The company anticipates a substantial increase in adjusted profits, signifying a strengthened market position and potential positive implications for stakeholders.
More about Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Limited is a Hong Kong-based company specializing in the pharmaceutical industry, focusing on innovative pharmaceutical products.
YTD Price Performance: 9.15%
Average Trading Volume: 4,099,032
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$18.52B
Learn more about 2096 stock on TipRanks’ Stock Analysis page.